Zobrazeno 1 - 10
of 12
pro vyhledávání: '"CHRISTINE DE BALINCOURT"'
Publikováno v:
Japanese Journal of Clinical Oncology. 49:727-733
Background New Japanese ethical guidelines for medical researches and the Clinical Trials Act have come into effect and monitoring is mandated for intervention studies. Methods of monitoring can be modified according to a study risk, but there is no
Publikováno v:
Remedium Journal about the Russian market of medicines and medical equipment. :46-63
The article presents a detailed analysis of the possibilities for the harmonious development of good clinical practice (GCP) to form objective standards for international cooperation in the circulation of medicines and other medical products. It refl
Autor:
Jaap Verweij, Jean-Yves Blay, Florence Duffaud, Eugenio Donato di Paola, Pancras C.W. Hogendoorn, Michael G Leahy, Christine de Balincourt, Camilla Fowst, Martine Van Glabbeke, Isabelle Ray-Coquard, Axel Le Cesne, Ian Judson
Publikováno v:
European Journal of Cancer. 43:308-315
The study aimed to assess the efficacy and safety of brostallicin, a new DNA minor groove binder, at a dose of 10 mg/m2, intravenous (i.v.) every three weeks, in patients with advanced or inoperable soft tissue sarcoma (STS) and gastrointestinal stro
Autor:
Christine de Balincourt, Wim J. Kirkels, Richard J. Sylvester, Adrian P.M. van der Meijden, Victor Zambon, Maurizio Brausi
Publikováno v:
Journal of Urology. 166:476-481
Purpose: After transurethral resection, we compared the efficacy and side effects of weekly intravesical instillations of epirubicin, bacillus Calmette-Guerin (BCG), and BCG plus isoniazid during a 6-week interval followed by 3 weekly maintenance ins
Autor:
P. D. J. Vegt, Christine de Balincourt, Wolfgang Höltl, Maurizio Brausi, Adrian P.M. van der Meijden, Richard J. Sylvester
Publikováno v:
The Journal of Urology. :1246-1249
Purpose: We analyzed the influence of the tuberculostatic agent isoniazid on the incidence and severity of adverse effects of intravesical bacillus Calmette-Guerin (BCG) therapy in patients with superficial bladder cancer.Materials and Methods: In a
Autor:
Hiroshi Katayama, Denis Lacombe, Kozo Kataoka, Junki Mizusawa, Christine de Balincourt, Kenichi Nakamura, Kenichi Miyamoto, Haruhiko Fukuda
Publikováno v:
Annals of Oncology. 26:vii117
Autor:
Christine de Balincourt, Richard Sylvester, Wolfgang Höltl, Maurizio Brausi, Pierfrancesco Bassi, Paola Ferrari, Doris Mack
Publikováno v:
Journal of Urology. 165:401-403
Low dose bacillus Calmette-Guerin (BCG) for stage TaT1 transitional cell carcinoma of the bladder has been given in various studies with the aim of decreasing side effects while maintaining the same efficacy as full dose bacillus Calmette-Guerin. How
Autor:
Pierre Kerbrat, Cornelis J. A. Punt, Christian Dittrich, Christine de Balincourt, Véronique Diéras, Denis Lacombe, Roberto Sorio, Pierre Fumoleau, F Caponigro, Xavier Paoletti
Publikováno v:
Investigational New Drugs, 21, 3, pp. 347-52
Investigational New Drugs, 21, 347-52
Investigational New Drugs, 21, 347-52
Item does not contain fulltext BACKGROUND: XR5000 is a tricyclic carboxamide-based cytotoxic agent that binds to DNA by intercalation and stimulates DNA cleavage by inhibition of both topoisomerase I and II. The aim of the present study was to evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34c56beab4dbeb30bc00c000e95aa6d9
https://doi.org/10.1023/A:1025476813365
https://doi.org/10.1023/A:1025476813365
Autor:
ADRIAN P. M. VAN DER MEIJDEN, MAURIZIO BRAUSI, VICTOR ZAMBON, WIM KIRKELS, CHRISTINE DE BALINCOURT, RICHARD SYLVESTER
Publikováno v:
The Journal of urology. 166(2)
After transurethral resection, we compared the efficacy and side effects of weekly intravesical instillations of epirubicin, bacillus Calmette-Guerin (BCG), and BCG plus isoniazid during a 6-week interval followed by 3 weekly maintenance instillation
Autor:
Victor Zambon, Christine de Balincourt, Richard Sylvester, Wim J. Kirkels, Adrian P.M. van der Meijden, Aldo V. Bono, Wolfgang Höltl, Maurizio Brausi
Publikováno v:
The Journal of Urology. :284